Cascade Investment Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$278K Sell
3,260
-1,125
-26% -$100K 0.18% 121
2025
Q4
$347K Hold
4,385
0.23% 103
2025
Q3
$351K Sell
4,385
-545
-11% -$46.5K 0.23% 100
2025
Q2
$448K Hold
4,930
0.31% 72
2025
Q1
$462K Buy
4,930
+10
+0.2% +$895 0.36% 64
2024
Q4
$447K Buy
4,920
+9
+0.2% +$859 0.32% 68
2024
Q3
$510K Sell
4,911
-5
-0.1% -$510 0.37% 66
2024
Q2
$477K Sell
4,916
-1,292
-21% -$119K 0.37% 62
2024
Q1
$559K Buy
6,208
+10
+0.2% +$847 0.42% 59
2023
Q4
$494K Buy
6,198
+10
+0.2% +$752 0.4% 64
2023
Q3
$440K Buy
6,188
+10
+0.2% +$748 0.42% 58
2023
Q2
$476K Buy
6,178
+9
+0.1% +$697 0.44% 62
2023
Q1
$464K Buy
6,169
+10
+0.2% +$744 0.46% 63
2022
Q4
$485K Buy
+6,159
New +$462K 0.51% 56

Other funds holding CL

Cascade Investment Group's CL Position: Q1 2026 in Review

Cascade Investment Group reduced its Colgate-Palmolive (CL) stake by 26% in Q1 2026, selling an estimated $100K and leaving 3,260 shares worth $278K. The position accounts for 0.18% of the portfolio, ranked #121.

Cascade Investment Group first reported a position in CL in Q4 2022 and has held it in 14 quarters since. The position peaked at $559K in Q1 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Cascade Investment Group held 3,260 shares of Colgate-Palmolive worth $278K as of Q1 2026.
  • Cascade Investment Group sold 1,125 Colgate-Palmolive shares in Q1 2026, an estimated $100K.
  • Colgate-Palmolive made up 0.18% of Cascade Investment Group's portfolio in Q1 2026, its #121 holding.
  • Cascade Investment Group first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • Cascade Investment Group's Colgate-Palmolive position peaked at $559K in Q1 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Cascade Investment Group's 13F filing for Q1 2026, filed 13 May 2026.